Cytodyn Inc (CYDY)

[jimmy667]

IncellDX Dr. Patterson's company supplied diagnostic tests for Leronlimab research. These tests are powerful but novel and have not gained widespread use. Also they are comparatively expensive. CytoDyn decided to use another diagnostic vendor for the Covid clinical trials. No IncellDX tests in the trials then no Dr. Patterson in the trials.
It is a simple matter of wanting to use the standard accepted diagnostic tests in the clinical trials so the reliability of the diagnostics does not introduce another factor to bring the results into question.
This was a fairly straightforward business decision and a good one. It is unfortunate that the incellDX tools are so new as they are very good but not in widespread use yet. It is unfortunate that Dr Patterson did not come with the other vendors tests as he is super qualified. Hopefully in the future CytoDyn can contract with IncellDX on more advanced trials in other indications.
This was a clinical development decision not a personality clash in some imaginary soap opera drama.
Dr Patterson did a lot to advance Leronlimab. He deserves a lot of credit but he has already been paid for his contribution. Likely he will be open to further collaboration in the future as a contractor for CytoDyn.
For now CytoDyn is better off using the conventional diagnostics as they are more widely accepted and understood.
Everything about the trials has been normal and natural. Speed bumps are par for the course and are expected.
We got this! Be patient the science will prove out.